Literature DB >> 9550393

Strength of TCR signal determines the costimulatory requirements for Th1 and Th2 CD4+ T cell differentiation.

X Tao1, S Constant, P Jorritsma, K Bottomly.   

Abstract

Differentiation of naive CD4 T cells into cytokine-secreting effector Th1 and Th2 cells is influenced by several factors. We have previously reported that the affinity of antigen for TCR and antigen dose can influence the differentiation of Th1 and Th2 cells. Several in vitro and in vivo models have demonstrated a role for the costimulatory molecules, B7-1 (CD80) and B7-2 (CD86), in the generation of distinct effector T cell responses. To determine whether the strength of TCR signaling controls the involvement of CD28 costimulation in selective CD4 T cell differentiation, naive CD4 T cells bearing a transgenic TCR are primed by a weak or strong TCR signal (signal 1) in the presence or absence of B7 costimulatory molecules (signal 2). In this system, IL-4-producing Th2 cells are generated by priming with a weak but not a strong TCR signal. Th2 cell differentiation is dependent on CD28/B7 interactions in that disruption of CD28/B7 interactions inhibits the priming of Th2 cells and cross-linking CD28 with anti-CD28 antibody augments the priming of Th2 cells. In contrast, however, IL-4-producing Th2 cells cannot be generated by priming with a strong TCR signal even in the presence of strong costimulation or high doses of IL-2. Thus, our results suggest that naive CD4 T cells are receptive to CD28-dependent IL-4 production only if they receive a weak TCR signal.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9550393

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  73 in total

Review 1.  Type 1 and type 2 immune responses in children: their relevance in juvenile arthritis.

Authors:  L R Wedderburn; P Woo
Journal:  Springer Semin Immunopathol       Date:  1999

Review 2.  Immunological synapse: a multi-protein signalling cellular apparatus for controlling gene expression.

Authors:  Kartika Padhan; Rajat Varma
Journal:  Immunology       Date:  2010-03       Impact factor: 7.397

3.  TCRβ repertoire of CD4+ and CD8+ T cells is distinct in richness, distribution, and CDR3 amino acid composition.

Authors:  Hoi Ming Li; Toyoko Hiroi; Yongqing Zhang; Alvin Shi; Guobing Chen; Supriyo De; E Jeffrey Metter; William H Wood; Alexei Sharov; Joshua D Milner; Kevin G Becker; Ming Zhan; Nan-ping Weng
Journal:  J Leukoc Biol       Date:  2015-09-22       Impact factor: 4.962

Review 4.  CD8⁺ T Cell-Independent Immune-Mediated Mechanisms of Anti-Tumor Activity.

Authors:  G Elizabeth Pluhar; Christopher A Pennell; Michael R Olin
Journal:  Crit Rev Immunol       Date:  2015       Impact factor: 2.214

5.  Trogocytosis-Mediated Intracellular Signaling in CD4+ T Cells Drives TH2-Associated Effector Cytokine Production and Differentiation.

Authors:  Jim Reed; Scott A Wetzel
Journal:  J Immunol       Date:  2019-04-08       Impact factor: 5.422

6.  Naive human T cells can be a source of IL-4 during primary immune responses.

Authors:  D M Bullens; K Rafiq; A Kasran; S W Van Gool; J L Ceuppens
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

7.  Quantitative events determine the differentiation and function of helper T cells.

Authors:  Anne O'Garra; Leona Gabryšová; Hergen Spits
Journal:  Nat Immunol       Date:  2011-04       Impact factor: 25.606

Review 8.  How are T(H)2-type immune responses initiated and amplified?

Authors:  William E Paul; Jinfang Zhu
Journal:  Nat Rev Immunol       Date:  2010-04       Impact factor: 53.106

9.  A 10-aa-long sequence in SLP-76 upstream of the Gads binding site is essential for T cell development and function.

Authors:  Lalit Kumar; Stefan Feske; Anjana Rao; Raif S Geha
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-14       Impact factor: 11.205

10.  Retinoic Acid Modulates Hyperactive T Cell Responses and Protects Vitamin A-Deficient Mice against Persistent Lymphocytic Choriomeningitis Virus Infection.

Authors:  Yuejin Liang; Panpan Yi; Xiaofang Wang; Biao Zhang; Zuliang Jie; Lynn Soong; Jiaren Sun
Journal:  J Immunol       Date:  2020-04-13       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.